4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004509
SVP, CHIEF TECHNICAL OFFICER gave up 15,292 shares (to pay taxes)
- SVP, CHIEF TECHNICAL OFFICER acquired 34,652 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-15 | Option exercise | +3,386 | 177,142 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-15 | Shares withheld for taxes | −1,304 | $58.29 | $76,010 | 175,838 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise | +20,891 | 196,729 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Shares withheld for taxes | −8,721 | $58.29 | $508,347 | 188,008 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise | +6,112 | 194,120 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Shares withheld for taxes | −3,103 | $58.29 | $180,874 | 191,017 | D |
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise | +4,263 | 195,280 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Shares withheld for taxes | −2,164 | $58.29 | $126,140 | 193,116 | D |
| Derivatives | |||||||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-15 | Option exercise · Restricted Stock Units | −3,386 | 0 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise · Performance Stock Units | −20,891 | 0 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise · Restricted Stock Units | −6,112 | 6,112 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-16 | Option exercise · Restricted Stock Units | −4,263 | 8,526 | D | ||
Loading xslF345X05/form4-02182025_110228.xml…